Sonoma Pharmaceuticals, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Sonoma Pharmaceuticals, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $18.63 million for the year ending 2021.

  • Sonoma Pharmaceuticals, Inc. showed an increase of +3.9% in Revenue From Contract With Customer Excluding Assessed Tax from 2020 to 2021.
  • This data is from Sonoma Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on July 14, 2021.
  • XBRL data for this metric is available from 2019 to 2021 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2019 to 2021), Sonoma Pharmaceuticals, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 1.8%.
  • Historical annual values: Fiscal year 2021: $18.63 million | Fiscal year 2020: $17.93 million | Fiscal year 2019: $18.97 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: